Diabetes Care, Vol 23, Issue 4 490-494, Copyright © 2000 by American Diabetes Association

ARTICLES

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

RK Stellato, HA Feldman, O Hamdy, ES Horton and JB McKinlay
New England Research Institutes, Watertown, Massachusetts, USA.

OBJECTIVE: The objective was to examine prospectively the association between low testosterone and sex hormone-binding globulin (SHBG) levels and the subsequent development of type 2 diabetes in men. RESEARCH DESIGN AND METHODS: Analyses were conducted on the cohort of the Massachusetts Male Aging Study, a population-based random sample of men aged 40-70. Of the 1,709 men enrolled in 1987-1989 (T1), 1,156 were followed up 7-10 years later (T2). Testosterone and SHBG levels at T1 were used to predict new cases of diabetes between T1 and T2. RESULTS: After controlling for potential confounders, diabetes at follow-up was predicted jointly and independently by lower baseline levels of free testosterone and SHBG. The odds ratio for future diabetes was 1.58 for a decrease of 1SD in free testosterone (4 ng/dl) and 1.89 for a 1SD decrease in SHBG (16 nmol/l), both significant at P < 0.02. CONCLUSIONS: Our prospective findings are consistent with previous, mainly cross-sectional reports, suggesting that low levels of testosterone and SHBG play some role in the development of insulin resistance and subsequent type 2 diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Mezuk, W. W. Eaton, S. Albrecht, and S. H. Golden Depression and Type 2 Diabetes Over the Lifespan: A meta-analysis Diabetes Care, December 1, 2008; 31(12): 2383 - 2390. [Abstract] [Full Text] [PDF]

				A. A. Yassin and F. Saad Testosterone and Erectile Dysfunction J Androl, November 1, 2008; 29(6): 593 - 604. [Abstract] [Full Text] [PDF]

				D. Rice, R. E. Brannigan, R. K. Campbell, S. Fine, L. Jack Jr, J. B. Nelson, and J. Regan-Klich Men's Health, Low Testosterone, and Diabetes: Individualized Treatment and a Multidisciplinary Approach The Diabetes Educator, November 1, 2008; 34(Supplement_5): 97S - 112S. [Abstract] [Full Text] [PDF]

				T. J. Murtola, T. L. J. Tammela, J. Lahtela, and A. Auvinen Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study Am. J. Epidemiol., October 15, 2008; 168(8): 925 - 931. [Abstract] [Full Text] [PDF]

				J. B. Farrell, A. Deshmukh, and A. A. Baghaie Low Testosterone and the Association With Type 2 Diabetes The Diabetes Educator, September 1, 2008; 34(5): 799 - 806. [Abstract] [Full Text] [PDF]

				V. Kupelian, F. J. Hayes, C. L. Link, R. Rosen, and J. B. McKinlay Inverse Association of Testosterone and the Metabolic Syndrome in Men Is Consistent across Race and Ethnic Groups J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3403 - 3410. [Abstract] [Full Text] [PDF]

				B. Mezuk, W. W. Eaton, S. H. Golden, and Y. Ding The Influence of Educational Attainment on Depression and Risk of Type 2 Diabetes Am J Public Health, August 1, 2008; 98(8): 1480 - 1485. [Abstract] [Full Text] [PDF]

				M. Grossmann, M. C. Thomas, S. Panagiotopoulos, K. Sharpe, R. J. MacIsaac, S. Clarke, J. D. Zajac, and G. Jerums Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1834 - 1840. [Abstract] [Full Text] [PDF]

				S. S. Kasturi, J. Tannir, and R. E. Brannigan The Metabolic Syndrome and Male Infertility J Androl, May 1, 2008; 29(3): 251 - 259. [Abstract] [Full Text] [PDF]

				S. Basaria and A. S. Dobs Testosterone Making an Entry Into the Cardiometabolic World Circulation, December 4, 2007; 116(23): 2658 - 2661. [Full Text] [PDF]

				A. B. Araujo, G. R. Esche, V. Kupelian, A. B. O'Donnell, T. G. Travison, R. E. Williams, R. V. Clark, and J. B. McKinlay Prevalence of Symptomatic Androgen Deficiency in Men J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4241 - 4247. [Abstract] [Full Text] [PDF]

				M. A. Yialamas, A. A. Dwyer, E. Hanley, H. Lee, N. Pitteloud, and F. J. Hayes Acute Sex Steroid Withdrawal Reduces Insulin Sensitivity in Healthy Men with Idiopathic Hypogonadotropic Hypogonadism J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4254 - 4259. [Abstract] [Full Text] [PDF]

				A. Rodriguez, D. C. Muller, E. J. Metter, M. Maggio, S. M. Harman, M. R. Blackman, and R. Andres Aging, Androgens, and the Metabolic Syndrome in a Longitudinal Study of Aging J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3568 - 3572. [Abstract] [Full Text] [PDF]

				S. A. Hall, S. T. Page, T. G. Travison, R. B. Montgomery, C. L. Link, and J. B. McKinlay Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1587 - 1594. [Abstract] [Full Text] [PDF]

				A. B. Araujo, V. Kupelian, S. T. Page, D. J. Handelsman, W. J. Bremner, and J. B. McKinlay Sex Steroids and All-Cause and Cause-Specific Mortality in Men Arch Intern Med, June 25, 2007; 167(12): 1252 - 1260. [Abstract] [Full Text] [PDF]

				D. Kapoor, H. Aldred, S. Clark, K. S. Channer, and T. H. Jones Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes: Correlations with bioavailable testosterone and visceral adiposity Diabetes Care, April 1, 2007; 30(4): 911 - 917. [Abstract] [Full Text] [PDF]

				E. Selvin, M. Feinleib, L. Zhang, S. Rohrmann, N. Rifai, W. G. Nelson, A. Dobs, S. Basaria, S. H. Golden, and E. A. Platz Androgens and Diabetes in Men: Results from the Third National Health and Nutrition Examination Survey (NHANES III) Diabetes Care, February 1, 2007; 30(2): 234 - 238. [Abstract] [Full Text] [PDF]

				T. G. Travison, A. B. Araujo, V. Kupelian, A. B. O'Donnell, and J. B. McKinlay The Relative Contributions of Aging, Health, and Lifestyle Factors to Serum Testosterone Decline in Men J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 549 - 555. [Abstract] [Full Text] [PDF]

				A. J. Tande, E. A. Platz, and A. R. Folsom The Metabolic Syndrome Is Associated with Reduced Risk of Prostate Cancer Am. J. Epidemiol., December 1, 2006; 164(11): 1094 - 1102. [Abstract] [Full Text] [PDF]

				A. O. Hammoud, M. Gibson, C. M. Peterson, B. D. Hamilton, and D. T. Carrell Obesity and Male Reproductive Potential J Androl, September 1, 2006; 27(5): 619 - 626. [Full Text] [PDF]

				M. Braga-Basaria, A. S. Dobs, D. C. Muller, M. A. Carducci, M. John, J. Egan, and S. Basaria Metabolic Syndrome in Men With Prostate Cancer Undergoing Long-Term Androgen-Deprivation Therapy J. Clin. Oncol., August 20, 2006; 24(24): 3979 - 3983. [Abstract] [Full Text] [PDF]

				M. M. Shores, A. M. Matsumoto, K. L. Sloan, and D. R. Kivlahan Low Serum Testosterone and Mortality in Male Veterans. Arch Intern Med, August 14, 2006; 166(15): 1660 - 1665. [Abstract] [Full Text] [PDF]

				A. Bojesen, K. Kristensen, N. H. Birkebaek, J. Fedder, L. Mosekilde, P. Bennett, P. Laurberg, J. Frystyk, A. Flyvbjerg, J. S. Christiansen, et al. The Metabolic Syndrome Is Frequent in Klinefelter's Syndrome and Is Associated With Abdominal Obesity and Hypogonadism Diabetes Care, July 1, 2006; 29(7): 1591 - 1598. [Abstract] [Full Text] [PDF]

				D Kapoor, E Goodwin, K S Channer, and T H Jones Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol., June 1, 2006; 154(6): 899 - 906. [Abstract] [Full Text] [PDF]

				M Fraenkel, J Caloyeras, S-G Ren, and S Melmed Sex-steroid milieu determines diabetes rescue in pttg-null mice. J. Endocrinol., June 1, 2006; 189(3): 519 - 528. [Abstract] [Full Text] [PDF]

				E. L. Ding, Y. Song, V. S. Malik, and S. Liu Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis JAMA, March 15, 2006; 295(11): 1288 - 1299. [Abstract] [Full Text] [PDF]

				H. K. Yaggi, A. B. Araujo, and J. B. McKinlay Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care, March 1, 2006; 29(3): 657 - 661. [Abstract] [Full Text] [PDF]

				V. Kupelian, S. T. Page, A. B. Araujo, T. G. Travison, W. J. Bremner, and J. B. McKinlay Low Sex Hormone-Binding Globulin, Total Testosterone, and Symptomatic Androgen Deficiency Are Associated with Development of the Metabolic Syndrome in Nonobese Men J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 843 - 850. [Abstract] [Full Text] [PDF]

				H. Hougaku, J. L. Fleg, S. S. Najjar, E. G. Lakatta, S. M. Harman, M. R. Blackman, and E. J. Metter Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E234 - E242. [Abstract] [Full Text] [PDF]

				N. Pitteloud, V. K. Mootha, A. A. Dwyer, M. Hardin, H. Lee, K.-F. Eriksson, D. Tripathy, M. Yialamas, L. Groop, D. Elahi, et al. Relationship Between Testosterone Levels, Insulin Sensitivity, and Mitochondrial Function in Men Diabetes Care, July 1, 2005; 28(7): 1636 - 1642. [Abstract] [Full Text] [PDF]

				E. S. Ford and S. Liu Invited Commentary: Acne in Adolescence--Protecting the Heart but Damaging the Prostate Later in Life? Am. J. Epidemiol., June 15, 2005; 161(12): 1102 - 1106. [Full Text] [PDF]

				N. Pitteloud, M. Hardin, A. A. Dwyer, E. Valassi, M. Yialamas, D. Elahi, and F. J. Hayes Increasing Insulin Resistance Is Associated with a Decrease in Leydig Cell Testosterone Secretion in Men J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2636 - 2641. [Abstract] [Full Text] [PDF]

				A. Karagiannis and F. Harsoulis Gonadal dysfunction in systemic diseases Eur. J. Endocrinol., April 1, 2005; 152(4): 501 - 513. [Abstract] [Full Text] [PDF]

				D. E. Laaksonen, L. Niskanen, K. Punnonen, K. Nyyssonen, T.-P. Tuomainen, V.-P. Valkonen, and J. T. Salonen The Metabolic Syndrome and Smoking in Relation to Hypogonadism in Middle-Aged Men: A Prospective Cohort Study J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 712 - 719. [Abstract] [Full Text] [PDF]

				P. Y. Liu, R. S. Swerdloff, and J. D. Veldhuis The Rationale, Efficacy and Safety of Androgen Therapy in Older Men: Future Research and Current Practice Recommendations J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4789 - 4796. [Abstract] [Full Text] [PDF]

				D. E. Laaksonen, L. Niskanen, K. Punnonen, K. Nyyssonen, T.-P. Tuomainen, V.-P. Valkonen, R. Salonen, and J. T. Salonen Testosterone and Sex Hormone-Binding Globulin Predict the Metabolic Syndrome and Diabetes in Middle-Aged Men Diabetes Care, May 1, 2004; 27(5): 1036 - 1041. [Abstract] [Full Text] [PDF]

				E. C. Tsai, A. M. Matsumoto, W. Y. Fujimoto, and E. J. Boyko Association of Bioavailable, Free, and Total Testosterone With Insulin Resistance: Influence of sex hormone-binding globulin and body fat Diabetes Care, April 1, 2004; 27(4): 861 - 868. [Abstract] [Full Text] [PDF]

				M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5076 - 5086. [Abstract] [Full Text] [PDF]

				C.J. Malkin, P.J. Pugh, T.H. Jones, and K.S. Channer Testosterone for secondary prevention in men with ischaemic heart disease? QJM, July 1, 2003; 96(7): 521 - 529. [Full Text] [PDF]

				M. Fukui, Y. Kitagawa, N. Nakamura, M. Kadono, S. Mogami, C. Hirata, N. Ichio, K. Wada, G. Hasegawa, and T. Yoshikawa Association Between Serum Testosterone Concentration and Carotid Atherosclerosis in Men With Type 2 Diabetes Diabetes Care, June 1, 2003; 26(6): 1869 - 1873. [Abstract] [Full Text] [PDF]

				P. T. Ellison, R. G. Bribiescas, G. R. Bentley, B. C. Campbell, S. F. Lipson, C. Panter-Brick, and K. Hill Population variation in age-related decline in male salivary testosterone Hum. Reprod., December 1, 2002; 17(12): 3251 - 3253. [Abstract] [Full Text] [PDF]

				S. M. Gapstur, P. H. Gann, P. Kopp, L. Colangelo, C. Longcope, and K. Liu Serum Androgen Concentrations in Young Men: A Longitudinal Analysis of Associations with Age, Obesity, and Race. : The CARDIA Male Hormone Study Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1041 - 1047. [Abstract] [Full Text] [PDF]

				N. Tamaya-Mori, K. Uemura, and A. Iguchi Gender Differences in the Dietary Lard-Induced Increase in Blood Pressure in Rats Hypertension, May 1, 2002; 39(5): 1015 - 1020. [Abstract] [Full Text] [PDF]

				A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99. [Full Text]

				J.-Y. Oh, E. Barrett-Connor, N. M. Wedick, and D. L. Wingard Endogenous Sex Hormones and the Development of Type 2 Diabetes in Older Men and Women: the Rancho Bernardo Study Diabetes Care, January 1, 2002; 25(1): 55 - 60. [Abstract] [Full Text] [PDF]

				D. Simon, M.-A. Charles, N. Lahlou, K. Nahoul, J.-M. Oppert, M. Gouault-Heilmann, N. Lemort, N. Thibult, E. Joubert, B. Balkau, et al. Androgen Therapy Improves Insulin Sensitivity and Decreases Leptin Level in Healthy Adult Men With Low Plasma Total Testosterone: A 3-month randomized placebo-controlled trial Diabetes Care, December 1, 2001; 24(12): 2149 - 2151. [Full Text] [PDF]

				K. M. Oltmanns, B. Fruehwald-Schultes, W. Kern, J. Born, H. L. Fehm, and A. Peters Hypoglycemia, But Not Insulin, Acutely Decreases LH and T Secretion in Men J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4913 - 4919. [Abstract] [Full Text] [PDF]